Management team

Michael K Schultz PhD

Chief Science Officer

Michael K Schultz PhD is a funded NIH investigator, Co-Founder and Chief Science Officer of Viewpoint Molecular Targeting, Inc. (now Perspective Therapeutics), and a tenured Associate Professor of Radiology, Pediatrics, Free Radical and Radiation Biology, and Chemistry at the University of Iowa (Iowa City, Iowa, USA).

Dr. Schultz has been involved in peptide-based radiopharmaceutical research and the development of new imaging and therapy agents for cancer for 20 years and has been a Project Leader in the Neuroendocrine Tumor Specialized Program of Research Excellence (SPORE) team at the University of Iowa since 2015. His expertise is cancer radiopharmaceutical sciences, radiochemistry, radiation biology, cancer oxidative metabolism and drug resistance, and bioconjugate chemistry with a focus on receptor targeted imaging-guided alpha-particle therapy for cancer. His recent publications demonstrate the potential for alpha-particle targeted radionuclide therapy; 203Pb based dosimetry for 212Pb based therapeutics; production of 203Pb/212Pb radiopharmaceuticals; ligand design; and generator produced radionuclides. Dr. Schultz and Viewpoint Co-founder Frances Johnson MD have secured approximately $18M in peer-reviewed grants and contracts from the National Cancer Institute of the National Institutes of Health; and secured Series A financing for Viewpoint in 2021. The company has been granted safe to proceed designations for two imaging trials and two therapeutic trials for its peptide-based 203Pb imaged-guided 212Pb alpha particle therapy for metastatic melanoma and neuroendocrine tumors and has recently received Fastrack designation by the US FDA for its alpha particle therapy for neuroendocrine tumors. Recently, the Viewpoint team completed a merger transaction with brachytherapy company Isoray to form Perspective Therapeutics (CATX, NYSE AMERICAN).

Ready to get started?

Have a question?ย We're always happy to chat about growing your business using the latest sales and marketing strategies!
Scroll to top